ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients

Massimo Volpe, Alejandro De La Sierra, Reinhold Kreutz, Stéphane Laurent, Athanasios J. Manolis

Research output: Contribution to journalArticle


Hypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and renal diseases. Thus, effective treatment of high blood pressure is an important strategy for reducing disease burden; however, in spite of the availability of numerous effective therapies only 30-40 % of patients with hypertension achieve the recommended blood pressure goals of

Original languageEnglish
Pages (from-to)137-147
Number of pages11
JournalHigh Blood Pressure and Cardiovascular Prevention
Issue number2
Publication statusPublished - 2014



  • Amlodipine
  • Cardiovascular disease
  • Cerebrovascular disease
  • Chronic kidney disease
  • Fixed dose combination
  • Hydrochlorothiazide
  • Hypertension
  • Olmesartan medoxomil
  • Risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Internal Medicine
  • Medicine(all)

Cite this